维普期刊资源整合服务平台（V6.5）

181篇 您的检索式：作者名="Vogel MA"

选中清除导出查看参考文献查看引证文献引用追踪共10页首页上一页第1页下一页末页 /10 跳转

	题名	作者	年代	出处	被引量
1	Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients显示文摘AIM: To determine the composition of both fecal and duodenal mucosa-associated microbiota in irritable bowel syndrome (IBS) patients and healthy subjects using molecular-based techniques. METHODS: Fecal and duodenal mucosa brush samples were obtained from 41 IBS patients and 26 healthy subjects. Fecal samples were analyzed for the composition of the total microbiota using fluorescent in situ hybridization (FISH) and both fecal and duodenal brush samples were analyzed for the composition of bif idobacteria using real-time polymerase chain reaction. RESULTS: The FISH analysis of fecal samples revealed a 2-fold decrease in the level of bifidobacteria (4.2 ± 1.3 vs 8.3 ± 1.9, P < 0.01) in IBS patients compared to healthy subjects, whereas no major differences in other bacterial groups were observed. At the species level, Bifidobacterium catenulatum levels were significantly lower (6 ± 0.6 vs 19 ± 2.5, P < 0.001) in the IBS patients in both fecal and duodenal brush samples than in healthy subjects.CONCLUSION: Decreased bifidobacteria levels in both fecal and duodenal brush samples of IBS patients compared to healthy subjects indicate a role for microbiotic composition in IBS pathophysiology.	Angèle PM Kerckhoffs Melvin Samsom Michel E van der Rest Joris de Vogel Jan Knol Kaouther Ben-Amor Louis MA Akkermans	2009	World Journal of Gastroenterology2009，15，23：	33
2	Hemodynamic effects of intermittent pneumatic compression of the lower limbs during laparo- scopic cholecystectomy 显示文摘	Christen Y Reymond MA Vogel J J	1995	Am J Surg1995，170，：	1
3	Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2- overexpressing netastatic breast cancer显示文摘	Vogel EL Cobleigh MA Tripathy D	2002	J Clin Oncol2002，20，3：	1
4	Increased overnight fluoride concentrations in saliva,plaque,and plaque fluid after a novel two -solution rinse显示文摘	Vogel GL Ma Y Carey CM		0，，03：	1
5	Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-over- expressing metastatic breast cancer 显示文摘	Vogel CL Cobleigh MA Tripathy D	2002	J Clin Oncol2002，20，3：	1
6	Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease显示文摘	Cobleigh MA Vogel CL Tripathy D	1999	JClin Oncol1999，17，9：	1
7	Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer显示文摘	Vogel CL Cobleigh MA Tripathy D		0，，03：	1
8	Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer 显示文摘	Vogel CL Cobleigh MA Tripathy D	2002	J Clin Oncol2002，20，3：	1
9	Genomic analysis reveals Lactobacillus sanfranciscensis as stable element in traditional sourdoughs 显示文摘	Vogel RF Pavlovic M Ehrmann MA Wiezer A Liesegang H Offschanka S Voget S Angelov A Bocker G Liebl W	2011	Microb Cell Fact2011，10，1：	1
10	Propionibacterium acnes in capsular bag distension syndrome 显示文摘	Kollias AN Vogel MA de Kaspar HM	2010	J Cataract Re- fract Surg2010，36，1：	1
11	First line, single-agent Herceptin (trastuzumab) in metastatic breast cancer : a pre-liminary report显示文摘	Vogel C Cobleigh MA Tripathy D	2001	Eur J Cancer2001，37，：	1
12	Efficacy and safety of Herceptin (trastuzumab humanized anti-HER2 antibody) as a single agent in first line treatment of HER2 overexpressing metastatic breast cancer(HER2+/MBC)显示文摘	Vogel CL Cobleigh MA Trpathy D	1998	Breast Cancer Res Treat1998，50，：	1
13	Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overex- pressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease 显示文摘	Cobleigh MA Vogel CL Tripathy D	1999	J Clin Oncol1999，17，9：	1
14	Efficacy and safety of Herceptin (humanized anti-HER2 antibody) as a single agent in 222 women with HER2 overexpression who relapsed following chemotherpy for metastatic breast cancer显示文摘	Cobleigh MA Vogel CL Tripathy D		Pro Am Soc Clin Oncol0，1，：	1
15	Efficacy and safety of tras- tuzumab as a single agent in first-line treatment of HER2-overexpress- ing metastatic breast cancer显示文摘	Vogel CL Cobleigh MA Tripathy D	2002	Journal of Clinical Oncology2002，20，3：	1
16	Toremifene for breast cancer: a review of 20 years of data 显示文摘	Vogel CL Johnston MA Capers C	2014	Clin Breast Cancer2014，14，1：	1
17	A haplotype encompassing the variant allele of DNA repair gene polymorphism ERCC2/XPD Lys751Gln hut not the variant allele of Asp312Asn is associated with risk of lung cancer in a northeastern Chinese population显示文摘	Yin J Vogel U Ma Y	2007	Cancer Genetics Cytogenetics2007，175，1：	1
18	Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease显示文摘	Cobleigh MA Vogel CL Tripathy D	1999	J Clin Oncol1999，17，9：	1
19	Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metasta-tic disease 显示文摘	Vogel CL Tripathy D	1999	J Clin Oncol1999，17，9：	1
20	First-line monotherapy in metastatic breast cancer显示文摘	Vogel CL Cobleigh MA Tripathy D	2001	Oncology2001，612，：	1

返回顶部每页显示：

共10页首页上一页第1页下一页末页 /10 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示